about
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studiesEvaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.Reorienting our view of particle-based adjuvants for subunit vaccines.Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscleBioinspired controlled release of CCL22 recruits regulatory T cells in vivoBiomimetic delivery with micro- and nanoparticlesControlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes.In vitro characterization of a sustained-release formulation for enfuvirtide.A retrospective mathematical analysis of controlled release design and experimentation.Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices.Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery.Delivery of rapamycin to dendritic cells using degradable microparticles.Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.Microparticulate systems for targeted drug delivery to phagocytes."Zero-dimensional" single-walled carbon nanotubes.Synthesis of poly(beta-amino ester)s with thiol-reactive side chains for DNA delivery.Poly(beta-amino ester) and cationic phospholipid-based lipopolyplexes for gene delivery and transfection in human aortic endothelial and smooth muscle cells.In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents.A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery.A mathematical model for release of biologics from porous hollow fibers.28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres.The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.Forming transmembrane channels using end-functionalized nanotubesModeling the self-assembly of lipids and nanotubes in solution: forming vesicles and bicelles with transmembrane nanotube channelsPatchy, anisotropic microspheres with soft protein isletsIn vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrateIn situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantationTreg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation
P50
Q34312430-AB046727-67B7-4C81-B714-C305FB05D7ABQ34312572-5C6917B7-8347-4F0B-AAF7-4617A6D74A61Q34794648-A024CF72-48B6-4477-819B-26921936D623Q35709212-5986F737-40C0-4DF0-BA85-7411F4A0E8B8Q35943638-31E2C53E-AF8D-42F3-9A5D-B9DFFB527A6AQ36379675-932C26EF-14BB-4D9B-8941-2BC407E7EBEBQ36768786-D1741909-491F-4C2E-BCBF-C72D909FA25DQ36998551-FEF961C5-B886-42DF-9F62-313D4E3CAB5EQ37319692-5DE59B99-F608-4652-A64A-588B55F5C048Q38325811-FC6282EC-5678-40D9-ADFB-B3E0E29EE1C7Q39547527-0A7E4A71-CD7C-4685-80C8-D53D2B393346Q40252161-649CE01F-2206-4CCE-8965-EAC9D7B97677Q40362968-8FB24618-21EC-4772-9660-AB02319966F6Q40383064-67042980-8A1A-4E91-A228-8CF0C053F7C5Q41842968-6DA24A4F-417D-4FB3-ADAE-7B0CED8A1F91Q42098676-CD3E1D34-C689-4024-BC89-6216A4079DB3Q42862823-1C235040-90CD-4333-BF3C-555FC1861A04Q43515398-61BA2BA3-484F-4BDA-87F4-6A60F4B03FD3Q43871647-38B07C50-147F-473A-B92B-683D85A85966Q44834648-B0010B6E-4BEF-4F65-AA29-A7A48C531E1DQ45944524-239FF50A-6DF5-4F25-936B-B8A0916F394AQ51352581-815E197B-71F9-46A1-8728-1AA7DBF20B30Q51438221-A00CAD3D-2C8E-405D-8AD6-4C13E9BF9760Q53512491-A7312B43-DBF9-4FA6-98C2-A134109AA438Q54199062-65C9427B-B4A8-4C35-A4BB-9902727C897BQ82057818-520FD625-D706-48FE-8F28-71CC52AF65D9Q84173372-88C94DCD-92AC-443F-A4F3-6CB8DD5F34E8Q84646829-156F1675-760C-48DA-A09A-82EE6D459BC1Q86066482-21571A0C-6434-4126-BC7C-90271119791AQ90578708-BF0758F9-864F-4255-81E4-A76FA8A70BD6Q91619164-627E093D-8087-4C24-B1EE-BA386F295420
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Steven R. Little
@ast
Steven R. Little
@en
Steven R. Little
@es
Steven R. Little
@nl
Steven R. Little
@sl
type
label
Steven R. Little
@ast
Steven R. Little
@en
Steven R. Little
@es
Steven R. Little
@nl
Steven R. Little
@sl
prefLabel
Steven R. Little
@ast
Steven R. Little
@en
Steven R. Little
@es
Steven R. Little
@nl
Steven R. Little
@sl
P106
P1153
35424276900
P21
P31
P496
0000-0002-7000-3931